Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 16c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $27.38 million versus the consensus estimate of $18.2 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Evercore ISI Upgrades Owens Corning (OC) to Outperform
• Taiwan Union Technology Corp (6274:TT) PT Raised to NT$2,115 at Nomura/Instinet